Global Automated External Defibrillator (AED) market is expected to grow rapidly over the forecast period. These are transportable electronic devices, which automatically detects and identifies cardiovascular diseases in patients and cure them through defibrillation. In sudden cardiac arrest, heartbeat stops suddenly and might result in death. Yet, it is different from a heart attack. The heart stops beating as its electrical system gets affected in a sudden cardiac arrest. While, a heart attack occurs due to blockage in the blood vessels which results in the disturbance in blood flow. Hence, an automated external defibrillator gives an electric shock to bring back the regular cardiac rhythm of the patient.
Browse Details of Automated
External Defibrillator Market at : https://www.millioninsights.com/industry-reports/automated-external-defibrillator-aed-market
Major factor driving the global
automated external defibrillator market include rising occurrences of
cardiovascular diseases and increased geriatric population. Other factors,
which boost the market demand, are changing demographics, increased levels of
stress, pollution, inadequate eating habits and work station exposure to
dangerous compounds such as extreme cold, smoke and lead. Few healthcare
regulatory agencies such as Medicare and Medicaid Services, the CDC, Agency for
Healthcare Research and Quality and European Heart Agency have taken
initiatives, which is expected to benefit the overall demand for automated
external defibrillator over the next seven years.
Furthermore, extensive
availability of medical amenities for patients suffering from sudden cardiac
arrest and development in medical technology also drive the overall market.
Rising installations of publically accessible AED, increasing awareness about
the lifesaving prospective of AED and growth in the number of patients
suffering from sudden cardiac arrests have also supported in the increase in
market size of AEDs.
Global automated external
defibrillator market is segmented based on technology and end user. On the
basis of technology, it is classified as semi-automated and fully automated
external defibrillators. On the basis of end user, the market is segmented into
five categories namely, hospitals, pre hospitals, public access, alternate care
and home. Automated external defibrillators play a vital role in saving the
lives of patients suffering from sudden cardiac arrest.
Bearing this potential in mind,
legislations have been passed which require installations of public access
defibrillators (PAD) in Japan, the U.S. and some European countries. The
external cardiac defibrillators is one of the fastest emerging segment while
internal/implantable cardiac defibrillators segment is one of the largest
segment. Rising awareness in the health care segment of The U.S. also accounts
for the growth in external cardiac defibrillators.
North America automated external
defibrillators demand accounted for the majority of the overall market in 2014.
North America has been benefitted mainly due to the increasing prevalence of
cardiovascular disorders and the rapidly developing technology in Canada and
The U.S. Recently, Japan and North America markets are anticipated to grow at a
relatively slower pace on account of a certain amount of saturation in the
market. North America was followed by Europe and China.
Get Sample Copy of
Automated External Defibrillator Market at : https://www.millioninsights.com/industry-reports/automated-external-defibrillator-aed-market/request-sample
Asia Pacific market is also
expected to witness a fast growth over the forecast period. Association with
Chinese, Korean and Indian companies for economical but high in quality
production of devices coupled with outsourcing marketing is projected to be the
major factors accounting for the growth in this region. Other factors such as
growing medical tourism, installation of manufacturing units, huge untapped
market, rising volumes of procedure and high scope for improving infrastructure
are expected to play a significant role in driving the demand for automated
external defibrillators market over the next seven years.
Major industry participants are
investing in research & development to come up with innovative production
techniques to cater to the existing hindrances in the market. Major industry
participants include Boston Scientific Corporation, Defibtech, General Electric
Company, HeartSine Tehnologies Inc., Koninklijke Philips N.V., Cardiac Science
Inc., Biotronik GmbH & Co. KG, Nihon Kohden Corporation, St. Jude Medical
Inc., Welch Allyn, GE Healthcare Ltd., Sorin SpA, Medtronic Inc., Philips
Healthcare and ZOLL Medical Corporation. Boston Scientific Corporation is
ground breaking in innovating and quick introduction of highly advanced FDA
accepted products. In 2014, it launched Inogen X4 CRT-D and Dynagen X4 device
that was intended for higher PNS threshold, prolonged battery life and easier
placement. ZOLL Medical Corporation provides an exclusive lightweight wearable
external defibrillator (LifeVest) on provisional basis by patients suffering
from long-term arrhythmic condition, to let physicians precisely evaluate the
condition and make well-informed decisions without conceding on the safety of
the patient.
No comments:
Post a Comment